how does retatrutide work for weight loss vs Tirzepatide vs Semaglutide Retatrutide: A Triple Agonist Shaping

The C20 fatty-diacid chain that gives GLP-3/RT its extended half-life is amphiphilic, so the molecule self-associates and readily generates foam

Getting my refills is so easy the reorder process is literally so effortless and my package arrived super fast

Your individual experience may vary

Always follow the storage and handling instructions in your specific medication's Instructions for Use (IFU)

MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): A randomised, open-label, parallel-group, multicentre, phase 3 trial